Clinical Trials Sponsored by Optimer Pharmaceuticals

Total 19628 results

Optimer Pharmaceuticals LLC

Completed

Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Clostridium Difficile-associated Diarrhea
Optimer Pharmaceuticals LLC

Completed

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Diarrhea | Clostridium Infections
Optimer Pharmaceuticals LLC

Completed

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea | Clostridium Infections

United States, France, United Kingdom, Belgium, Spain, Canada, Germany, Italy, Sweden
Optimer Pharmaceuticals LLC

Completed

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Diarrhea

United States
Optimer Pharmaceuticals LLC

Completed

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001) (DEFLECT-1)

Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC

Completed

Safety and Efficacy of Prulifloxacin vs Placebo in Treatment of Acute Gastroenteritis in Adult Travelers

Acute Bacterial Gastroenteritis

India
Hartford Hospital
Optimer Pharmaceuticals LLC

Completed

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

Clostridium Difficile Infection

United States
MedDay Pharmaceuticals SA
Eurofins Optimed

Terminated

HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects

Healthy Volunteers | Hepatic Impairment of Moderate Child Pugh Category

France, Hungary
MedDay Pharmaceuticals SA
Eurofins Optimed

Terminated

RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects

Healthy Volunteers | Impaired Renal Function

France, Hungary
Boston Medical Center
Cepheid; Optimer Pharmaceuticals LLC

Completed

Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients

Crohn's Disease | Ulcerative Colitis | Inflammatory Bowel Disease | Clostridium Difficile

United States
Generica Pharmaceuticals
Optimum Contract Research Organisation

Completed

Efficacy and Safety of NEM® Brand Eggshell Membrane in Patients With Grade 2/3 Knee Osteoarthritis

Osteoarthritis, Knee

Turkey
Mapreg
Eurofins Optimed

Recruiting

RESIST : Administration of MAP4343 in Antidepressant Non-Responders Patients Experiencing a Major Depressive Episode

Depression

France
Sublimed
Eurofins Optimed

Unknown

Comparison of the Efficacy, Tolerability and Safety of actiTENS to Those of Level 2 Analgesic Treatments. (ArthroTENS)

Knee Osteoarthritis

France
Enterome
Eurofins Optimed

Terminated

MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients (MOBIDIC)

Crohn's Disease

United States, France, United Kingdom
Amazentis SA
Eurofins Optimed

Completed

A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects

Aging | Muscle Function | Mitochondrial Dysfunction

France
Lesaffre International
Eurofins Optimed

Terminated

Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis

Vulvo-vaginal Candidiasis

France
Optimed Medizinische Instrumente GmbH

Completed

Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study

Post-thrombotic Syndrome | Iliac Vein Compression Syndrome

Switzerland, Austria, Germany, Netherlands
Sir Mortimer B. Davis - Jewish General Hospital
Novartis Pharmaceuticals

Withdrawn

Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries

Hypertension | Diabetes

Canada
Danisco France SAS
Eurofins Optimed

Completed

Effect of Study Probiotics on Body Fat Mass in Overweight and Obese Individuals Following Healthy Lifestyle Intervention (QLSlimCapHL)

Obesity | Overweight

France, Spain
Unilever R&D
Eurofins Optimed

Completed

Comparison of the Satiety Effect of a Very Low Energy Foam With Normal Energy Foams

Satiety | Appetite
Bledina
Optimed Medizinische Instrumente GmbH

Completed

Prevention of Cow's Milk Allergy in Children

Milk Hypersensitivity

France
OptMed, Inc.

Completed

Safety and Efficacy Study of BondEase to Treat Traumatic Lacerations and Surgical Incisions

Traumatic Lacerations or Surgical Incisions

United States
Yoplait France SAS
Eurofins Optimed

Completed

Effect of Consumption of Yogurt Fortified in Calcium and Vit. D on Circulating Levels of 25OHD in Postmenopausal Women

Vitamin D Deficiency | Menopause

France
Quantum Genomics SA
Eurofins Optimed

Completed

Pharmacokinetics in End Stage Renal Disease Patients

Renal Failure | Healthy Volunteers

France
Danisco Sweeteners Oy
Eurofins Optimed

Completed

Effects of Probiotic Supplementation on Colonic Transit Time and Gastrointestinal Symptoms in Adults With Constipation.

Constipation | Gastrointestinal Disorder

France
Optimal Health Research

Completed

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Breast Cancer | Lung Cancer | Prostate Cancer

United States
Optimal Acuity Corporation

Completed

Observational Study of Vision Improvement in Patients With Retinal Disorders

Age-related Macular Degeneration | Diabetic Macular Edema

Canada
Optimal Health Research

Completed

A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome (PLDS)

Post-Lyme Disease Syndrome (PLDS)

United States
Optimal Health Research

Completed

Effectiveness of a Nutraceutical in Raising Circulating Serum Vitamin, Mineral and Amino Acid Levels in Patients.

Vitamin Deficiency

United States
Optimal Acuity Corporation

Not yet recruiting

Vision Improvement for Legally Blind Dry AMD Patients

Dry Age-related Macular Degeneration | Vision Impairment and Blindness
Optimal Health Research

Active, not recruiting

Diet Effect on Cancer Treatment Outcome

Cancer Breast | Cancer Prostate

United States, India
Octimet Oncology N.V.

Terminated

OMO-1 in Solid Malignancies

Neoplasms

France, United Kingdom, Netherlands, United States, Belgium
Optimal Health Research

Completed

Treating Post-Lyme Disease Syndrome With Acetogenins

Post-Lyme Disease Syndrome (PLDS)

United States
Optimal Health Research

Completed

Eradication of Malignant Carcinoma in the Breast Tissue

Breast Cancer
Optimum Therapeutics, LLC

Terminated

Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Optimal Health Research

Completed

Eradication of Prostate Cancer Using F-989

Prostate Cancer
Genfit
Eurofins Optimed; PhinC Development; CardiaBase

Completed

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Healthy Volunteers

France
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Rede Optimus Hospitalar SA

Recruiting

Shockwave IVL + DCB

Calcified Lesions in Small Coronary Vessels

Italy, Brazil
Optimus Clinical Research
CareFusion

Completed

A Controlled Trial of Vertebroplasty for Acute Painful Osteoporotic Fractures

Vertebral Compression Fractures | Osteoporotic Vertebral Compression Fractures | Acute Vertebral Fractures

Australia
Rede Optimus Hospitalar SA

Not yet recruiting

TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI (TRAFIC-PTA)

Trans-femoral TAVI With Calcified Ilio-femoral Arteries
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA2)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Terminated

Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee (FACT CLBP 1)

Osteoarthritis | Chronic Low Back Pain

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Melior Pharmaceuticals
Bukwang Pharmaceutical, Co., Ltd.

Completed

Adult Subjects With Uncontrolled Type 2 Diabetes

Type 2 Diabetes

United States

Clinical Trials Sponsored by Optimer Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations